Clorox CLX
1,007 filings, 7 in the last 30 days
SEC filing indexWhat the 8-Ks said
2 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Oct 29, 2026 CEO, CFO, COO or CAOCEO change “On October 28, 2026, the Board of Directors (the “Board”) of The Clorox Company (the “Company”), appointed Fabian Garcia to serve as the Chief Executive Officer (“CEO”) of the Company and a member of the Board, effective as of January 5, 2027 (the “Effective Date”).” 8-K item 5.02 · all documents
- May 28, 2026 CEO, CFO, COO or CAOCEO change “(b) On May 26, 2026, Linda Rendle, Chair of the Board of Directors (the “Board”) and Chief Executive Officer (“CEO”) of The Clorox Company (the “Company”), asked the Board to initiate a CEO search process, as she has made the decision to step down for health reasons.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 34 events
- Nov 5, 2026 Buy Breber Pierre R (Director) bought $400Kopen-market purchase on Nov 4, 2026
- Nov 2, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Nov 2, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 29, 2026 Officer CEO changeOn October 28, 2026, the Board of Directors (the “Board”) of The Clorox Company (the “Company”), appointed Fabian Garcia to serve as the Chief Executive Officer (“CEO”) of the Company and a member of the Board, effective as of January 5, 2027 (the “Effective Date”).
- Aug 7, 2026 10-K Annual report (10-K)period ended Jun 30, 2026
- Aug 3, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Jun 17, 2026 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- May 28, 2026 Officer CEO change(b) On May 26, 2026, Linda Rendle, Chair of the Board of Directors (the “Board”) and Chief Executive Officer (“CEO”) of The Clorox Company (the “Company”), asked the Board to initiate a CEO search process, as she has made the decision to step down for health reasons.
- May 11, 2026 8-K Other events8-K item 8.01
- May 5, 2026 Buy Breber Pierre R (Director) bought $429Kopen-market purchase on May 5, 2026
- May 1, 2026 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · Under this shelf registration process, from time to time we may offer and sell securities evidencing our senior unsecured indebtedness in one or more series up to an indeterminate aggregate principal amount.
- Apr 30, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Apr 30, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 1, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Mar 10, 2026 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Feb 3, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 3, 2026 10-Q Quarterly report (10-Q)period ended Dec 31, 2025
- Jan 22, 2026 8-K Regulation FD disclosure, Other events8-K items 7.01, 8.01
- Nov 20, 2025 8-K Shareholder vote results8-K item 5.07
- Nov 3, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Nov 3, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 30, 2025 8-K Director or officer change8-K item 5.02
- Aug 8, 2025 10-K Annual report (10-K)period ended Jun 30, 2025
- Jul 31, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 23, 2025 8-K Bylaws or fiscal year changed8-K item 5.03
- May 12, 2025 8-K Director or officer change8-K item 5.02
- May 5, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 5, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Mar 28, 2025 8-K Material agreement signed, Material agreement ended, New debt or obligation8-K items 1.01, 1.02, 2.03
- Feb 3, 2025 Planned sale Kirsten Marriner (executive vice president - chief people and corporate affairs officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 8,227 shares, runs to Mar 2, 2027
- Feb 3, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 3, 2025 10-Q Quarterly report (10-Q)period ended Dec 31, 2024
- Jan 28, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Nov 21, 2024 8-K Shareholder vote results, Other events8-K items 5.07, 8.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 10, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Nov 5, 2026 | 4 | Insider trade |
| Nov 2, 2026 | 10-Q | Quarterly report |
| Nov 2, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Oct 29, 2026 | DEFA14A | Extra proxy material |
| Oct 29, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Oct 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 7, 2026 | ARS | Annual report to shareholders |
| Oct 7, 2026 | DEFA14A | Extra proxy material |
| Oct 7, 2026 | DEF 14A | Proxy statement |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 2, 2026 | 4 | Insider trade |
| Oct 2, 2026 | 4 | Insider trade |
| Oct 2, 2026 | 4 | Insider trade |
| Oct 2, 2026 | 4 | Insider trade |
| Oct 2, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Sep 25, 2026 | 4 | Insider trade |
| Aug 7, 2026 | 10-K | Annual report |
| Aug 3, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jul 24, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 2, 2026 | 4 | Insider trade |
| Jun 25, 2026 | 11-K | Employee plan annual report |
| Jun 25, 2026 | 11-K | Employee plan annual report |
| Jun 22, 2026 | 4 | Insider trade |
| Jun 22, 2026 | 4 | Insider trade |
| Jun 22, 2026 | 4 | Insider trade |
| Jun 22, 2026 | 4 | Insider trade |
| Jun 17, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Jun 1, 2026 | SD | Conflict minerals report |
| May 28, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| May 11, 2026 | 8-K | Other events |
| May 8, 2026 | 424B2 | Prospectus (notes) |
| May 6, 2026 | FWP | Offering terms |
| May 6, 2026 | 424B3 | |
| May 5, 2026 | 4 | Insider trade |
| May 1, 2026 | S-3ASR | Shelf registration |
| Apr 30, 2026 | 10-Q | Quarterly report |
| Apr 30, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 3, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 2, 2026 | 4 | Insider trade |
| Apr 1, 2026 | 8-K | Regulation FD disclosure, Other events |
| Mar 26, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 10, 2026 | 8-K | Material agreement signed, New debt or obligation |
| Feb 3, 2026 | 10-Q | Quarterly report |
| Feb 3, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jan 22, 2026 | 8-K | Regulation FD disclosure, Other events |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Jan 5, 2026 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 4 | Insider trade |
| Nov 24, 2025 | 4 | Insider trade |
| Nov 20, 2025 | 8-K | Shareholder vote results |
| Nov 3, 2025 | 10-Q | Quarterly report |
| Nov 3, 2025 | 8-K | Quarterly results, Regulation FD disclosure |
| Oct 30, 2025 | 8-K | Director or officer change |
| Oct 7, 2025 | ARS | Annual report to shareholders |
| Oct 7, 2025 | DEFA14A | Extra proxy material |
| Oct 7, 2025 | DEF 14A | Proxy statement |
| Oct 7, 2025 | 4 | Insider trade |
| Oct 7, 2025 | 4 | Insider trade |
| Oct 7, 2025 | 4 | Insider trade |
| Oct 7, 2025 | 4 | Insider trade |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CLX/export.csv") into a cell.